Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jul 08 2025
- Completion Of Export-Sourcing Orders Aggregating Rs. 299.91 Crores
- Welcure Wins New? 856 Million Export-Sourcing Orders From Giant Exim & Ravina International - Reg-30 Disclosure
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 30 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 27 2025
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of Securities AndExchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jul 31 2025
- Board Meeting Outcome for Outcome Of Board Meeting
- Standalone Unaudited Financial Results For The 1St Quarter Ended 30Th June 2025
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals